desalting_params:
  basic_anions:
    - CHLORIDE
    - DIOXIDE
    - OXIDE
    - ACETATE
    - SULFATE
    - PHOSPHATE
    - HYDROXIDE
    - HYDROCHLORIDE
    - CITRATE
    - DIACETATE
    - TRIACETATE
    - ADIPATE
    - TARTRATE
    - BITARTRATE
    - FUMARATE
    - HEMIFUMARATE
    - MALEATE
    - BROMIDE
    - MEGLUMINE
    - BICARBONATE
    - MESYLATE
    - DISULFIDE
    - FLUORIDE
    - GLYCEROPHOSPHATE
    - GLUCEPTATE
    - NITRITE
    - HYDROBROMIDE
    - SUCCINATE
    - TEREPHTHALATE
    - CARBONATE  
    - HYDROBROMIDE
    - BENZOATE 
    - BITARTRATE
    - FUROATE
    - PAMOATE
    - VALERATE
    - BESYLATE
    - TOSYLATE
    - METHYLSULFATE
    - SUCCINATE
    - LACTATE
    - DIPHOSPHATE
    - DIPROPIONATE
    - PROPIONATE
    - DIPOTASSIUM
  
  basic_cations:
    - FERROUS
    - CALCIUM
    - SODIUM
    - MAGNESIUM
    - MANGANESE
    - POTASSIUM
    - DIPOTASSIUM
    - ALUMINUM
    - TITANIUM
    - COPPER
    - CUPRIC
    - LYSINE
    - DISODIUM
    - ZINC
    - IODINE
  other_identifiers:
    - HYDRATE
    - MONOHYDRATE
    - DIHYDRATE
    - TRIHYDRATE
    - TETRAHYDRATE
    - HEPTAHYDRATE
    - ANHYDROUS
    - MONOBASIC
    - DIBASIC
    - LYSINE
    - ARGININE
    - POLISTIREX
    - COMPLEX
    - PRECIPITATED
    - DIMETHYL
    - ANHYDROUS
    - PENTAVALENT

# PURPLE BOOK
delimiters_purplebook:
  - " and "
  - ", with "
split_exclusions_purplebook:
  - ""
purplebook_drug_name_column: Proper Name
purplebook_approval_date_column: Approval Date
marketing_status_column_purplebook: Licensure
discontinued_marker_purplebook: Voluntarily Revoked

# INDIA
india_drug_name_column: Drug Name
india_approval_date_column: Date of Approval
delimiters_india:
  - " + "
  - " ; "
  - " and "
split_exclusions_india:
  - ""

# ORANGE BOOK
split_exclusions_orangebook:
  - LIOTRIX (T4;T3)
orangebook_drug_name_column: Ingredient
orangebook_approval_date_column: Approval_Date
delimiters_orangebook:
  - " AND "
  - " ; "
  - " W/ "
  - "; "
marketing_status_column_orangebook: "Type"
discontinued_marker_orangebook: "DISCN"

# PMDA
exclusions_pmda:
  - HYDROCHLOROTHIAZID E
  - IPRAGLIFLOZIN L- PROLINE
  - IRON(III)HEXACYANOFERRATE(I I)
  - L
  - L -MENTHOL
  - LEVOCARNITINE CHLORIDE
  - LIDOCAINE HYDROCHLORIDE MONOHYDRATE LIDOCAINE HYDROCHLORIDE
  - ML
  - N/A BECAUSE OF A COMBINATION DRUG
  - N/A BECAUSE OF A NEW COMBINATION DRUG
  - N/A FOR THIS COMBINATION DRUG
  - N/A FOR THIS DRUG USED FOR PATCH TESTS
  - OTERA CIL POTASSIUM
  - OTERACIL POTASSIUM.
  - PALIPERIDONE PALMITATE
  - PAMIDRONATE DISODIUM HYDRATE
  - PROPITOCAIN E
  - TAZOBACTAM SODIUM
  - TERIPARATIDE ACETATE
  - TOCILIZUMAB (GENETICAL RECOMBINATION
  - TOSUFLOXACIN TOSILATE HYDRATE
  - VARDENAFIL HYDROCHLORIDE HYDRATE
  - ZINC ACETATE HYDRATE
  - ""
  - NA
  - N; A FOR THIS DRUG USED FOR PATCH TESTS
  - COMBINATION DRUG CONTAINING TEGAFUR, GIMERACIL, AND OTERACIL POTASSIUM.
  - TEGAFUR/GIMERACIL/OTERA CIL POTASSIUM
  - A COMBINATION DRUG OF TEGAFUR, GIMERACIL, AND OTERACIL POTASSIUM
  - N; A FOR THIS DRUG USED FOR PATCH TESTS
  - 52;
  - W;
  - 23F;
  - "(UNDERLINED: NEW ACTIVE INGREDIENTS)"


split_exclusions_pmda:
  - NEISSERIA MENINGITIDIS POLYSACCHARIDES CONJUGATED TO TETANUS TOXOID (SEROGROUPS A, C, W, AND Y)
  - PNEUMOCOCCAL POLYSACCHARIDES OF SEROTYPES 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, AND 33F CONJUGATED TO CRM197 CARRIER PROTEIN
  - N/A FOR THIS DRUG USED FOR PATCH TESTS
  - PNEUMOCOCCAL 10- VALENT CONJUGATE VACCINE ADSORBED (NON-TYPEABLE HAEMOPHILUS INFLUENZAE (NTHI) PROTEIN D, DIPHTHERIA OR TETANUS TOXOID CONJUGATES)
  - LIVE ATTENUATED HUMAN ROTAVIRUS VACCINE, ORAL
  - LIVE ATTENUATED INFLUENZA VIRUS (TYPE A AND TYPE B)
  - ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, EQUINE
  - ANDEXANET ALFA
  - N/A FOR THIS COMBINATION DRUG
  - LIVE ATTENUATED ROTAVIRUS VACCINE, ORAL, PENTAVALENT
  - INACTIVATED INFLUENZA VIRUS, H5N1 (WHOLE VIRION)
  - FREEZE-DRIED LIVE ATTENUATED MEASLES, RUBELLA COMBINED VACCINE
  - FREEZE-DRIED, CELL CULTURE- DERIVED JAPANESE ENCEPHALITIS VACCINE （INACTIVATED）
  - ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, RABBIT
  - N/A BECAUSE OF A NEW COMBINATION DRUG
  - N/A BECAUSE OF A COMBINATION DRUG
  - INACTIVATED INFLUENZA VIRUS, H5N1 (WHOLE VIRION)
  - FREEZE-DRIED LIVE ATTENUATED MEASLES AND RUBELLA COMBINED
  - INACTIVATED SPLIT-VIRUS INFLUENZA A (A/CALIFORNIA/7/2009 [H1N1])
  - PANDEMIC INFLUENZA VIRUS SURFACE ANTIGENS OF A/CALIFORNIA/7/2009 (H1N1) LIKE STRAIN
  - FREEZE-DRIED BACILLUS OF CALMETTE AND GUERIN FOR INTRAVESICAL USE (CONNAUGHT STRAIN)
  - HUMAN PAPILLOMAVIRUS L1 PROTEIN VIRUS-LIKE PARTICLES (TYPES 6, 11, 16, 18, 31, 33, 45, 52, AND 58)
  - STANDARDIZED JAPANESE CEDAR POLLEN EXTRACT ORIGINAL SOLUTION 10,000 JAU/ML
  - HUMAN PAPILLOMAVIRUS L1 PROTEIN VIRUS-LIKE PARTICLES (TYPES 6; 11; 16; 18; 31; 33; 45; 52;; 58)
  - PNEUMOCOCCAL POLYSACCHARIDES OF SEROTYPES 1; 3; 4; 5; 6A; 6B; 7F; 9V; 14; 18C; 19A; 19F; 22F; 23F;; 33F CONJUGATED TO CRM197 CARRIER PROTEIN
  - CANDESARTAN CILEXETIL
  - DERMATOPHAGOIDES FARINAE EXTRACT 10; 000 AU; ML; DERMATOPHAGOIDES PTERONYSSINUS EXTRACT 10; 000 AU; ML
  - DERMATOPHAGOIDES FARINAE EXTRACT 10; 000 AU; ML; DERMATOPHAGOIDES PTERONYSSINUS EXTRACT 10; 000 AU; ML
  - IBANDRONATE SODIUM HYDRATE 
  - VANDETANIB 
  - IBANDRONATE SODIUM HYDRATE
  - LANDIOLOL HYDROCHLORIDE 
  - LANDIOLOL HYDROCHLORIDE
  - NICORANDIL
  - LANDIOLOL HYDROCHLORIDE 
  - DERMATOPHAGOIDES FARINAE EXTRACT 10,000 AU/ML, DERMATOPHAGOIDES PTERONYSSINUS EXTRACT 10,000 AU/ML
  - LIVE ATTENUATED HUMAN ROTAVIRUS VACCINE; ORAL
  - INACTIVATED INFLUENZA VIRUS; H5N1 (WHOLE VIRION)
  - INACTIVATED SPLIT-VIRUS INFLUENZA A (A; CALIFORNIA; 7; 2009 [H1N1])
  - PANDEMIC INFLUENZA VIRUS SURFACE ANTIGENS OF A; CALIFORNIA; 7; 2009 (H1N LIKE STRAIN
  - PNEUMOCOCCAL 10- VALENT CONJUGATE VACCINE ADSORBED (NON-TYPEABLE HAEMOPHILUS INFLUENZAE (NTHI) PROTEIN D; DIPHTHERIA OR TETANUS TOXOID CONJUGATES)
  - NEISSERIA MENINGITIDIS POLYSACCHARIDES CONJUGATED TO TETANUS TOXOID (SEROGROUPS A; C; W;; Y)
  - HUMAN PAPILLOMAVIRUS L1 PROTEIN VIRUS-LIKE PARTICLES (TYPES 6; 11; 16; 18; 31; 33; 45; 52;; 58)
  - PNEUMOCOCCAL POLYSACCHARIDES OF SEROTYPES 1; 3; 4; 5; 6A; 6B; 7F; 9V; 14; 18C; 19A; 19F; 22F; 23F;; 33F CONJUGATED TO CRM197 CARRIER PROTEIN
  - DERMATOPHAGOIDES FARINAE EXTRACT 10; 000 AU; ML; DERMATOPHAGOIDES PTERONYSSINUS EXTRACT 10; 000 AU; ML
  - STANDARDIZED JAPANESE CEDAR POLLEN EXTRACT ORIGINAL SOLUTION 10; 000 JAU; ML
  - PNEUMOCOCCAL POLYSACCHARIDES OF SEROTYPES 1; 3; 4; 5; 6A; 6B; 7F; 9V; 14; 18C; 19A; 19F; 22F; 23F;; 33F CONJUGATED TO CRM197 CARRIER PROTEIN
  - HUMAN PAPILLOMAVIRUS L1 PROTEIN VIRUS-LIKE PARTICLES (TYPES 6; 11; 16; 18; 31; 33; 45; 52;; 58)
  - "MAGNESIUM	SULFATE; GLUCOSE"
  - DERMATOPHAGOIDES FARINAE EXTRACT 10; 000 AU; ML; DERMATOPHAGOIDES PTERONYSSINUS EXTRACT 10; 000 AU; ML
  - NEISSERIA MENINGITIDIS POLYSACCHARIDES CONJUGATED TO TETANUS TOXOID (SEROGROUPS A; C; W;; Y)
  - STANDARDIZED JAPANESE CEDAR POLLEN EXTRACT ORIGINAL SOLUTION 10; 000 JAU; ML
  - PANDEMIC INFLUENZA VIRUS SURFACE ANTIGENS OF A; CALIFORNIA; 7; 2009 (H1N LIKE STRAIN
  - INACTIVATED SPLIT-VIRUS INFLUENZA A (A; CALIFORNIA; 7; 2009 [H1N1])
  - PNEUMOCOCCAL POLYSACCHARIDES OF SEROTYPES 1; 3; 4; 5; 6A; 6B; 7F; 9V; 14; 18C; 19A; 19F; 22F; 23F;; 33F CONJUGATED TO CRM197 CARRIER PROTEIN
  - CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
  
pmda_drug_name_column: "Active Ingredient (underlined: new active ingredient)"
pmda_approval_date_column: Approval Date
delimiters_pmda: 
  - ";"
  # - ", "
  # - " and "
  # - " / "

# EMA
delimiters_ema:
  - ", "
  - "/"
  - " AND "
ema_drug_name_column: International non-proprietary name (INN) / common name
ema_approval_date_column: Marketing authorisation date
split_exclusions_ema:
  - MENINGOCOCCAL GROUP B VACCINE (RECOMBINANT, ADSORBED)
  - PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)
  - PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (20-VALENT, ADSORBED)
  - COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - ZOONOTIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (WHOLE VIRION, INACTIVATED, PREPARED IN CELL CULTURE)
  - COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)
  - DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)
  - EBOLA ZAIRE VACCINE (RVSV∆G-ZEBOV-GP, LIVE)
  - INFLUENZA VACCINE (LIVE ATTENUATED, NASAL)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - QUADRIVALENT INFLUENZA VACCINE (RECOMBINANT, PREPARED IN CELL CULTURE)
  - HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE (RECOMBINANT, ADSORBED)
  - MENINGOCOCCAL GROUP B VACCINE (RDNA, COMPONENT, ADSORBED)
  - MENINGOCOCCAL GROUPS A, C, W-135 AND Y CONJUGATE VACCINE
  - MENINGOCOCCAL GROUP A, C, W-135 AND Y CONJUGATE VACCINE
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
  - COVID-19 VACCINE (INACTIVATED, ADJUVANTED, ADSORBED)
  - EX VIVO EXPANDED AUTOLOGOUS HUMAN CORNEAL EPITHELIAL CELLS CONTAINING STEM CELLS
  - RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)
  - ROTAVIRUS VACCINE, LIVE
  - IBANDRONIC ACID
  - INACTIVATED VACCINE AGAINST FOOT-AND-MOUTH DISEASE
  - RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E
  - JAPANESE ENCEPHALITIS VACCINE (INACTIVATED, ADSORBED)
  - HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
  - HEPATITIS B (RDNA) VACCINE (ADJUVANTED, ADSORBED)
  - HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)
  - SMALLPOX AND MONKEYPOX VACCINE (LIVE MODIFIED VACCINIA VIRUS ANKARA)
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)
  - HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)
  - DEFATTED POWDER OF ARACHIS HYPOGAEA L., SEMEN (PEANUTS)
  - MEASLES, MUMPS, RUBELLA AND VARICELLA VACCINE (LIVE)
  - MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)
  - HUMAN COAGULATION FACTOR VIII / HUMAN VON WILLEBRAND FACTOR
  - VACCINE AGAINST FELINE VIRAL RHINOTRACHEITIS, FELINE CALICIVIROSIS, FELINE PANLEUCOPENIA, FELINE LEUKEAMIA AND FELINE CHLAMYDOPHILA INFECTIONS
  - VACCINE AGAINST FELINE VIRAL RHINOTRACHEITIS, FELINE CALICIVIROSIS, FELINE PANLEUCOPENIA AND FELINE LEUKAEMIA
  - VACCINE AGAINST FELINE VIRAL RHINOTRACHEITIS, FELINE CALICIVIROSIS, FELINE PANLEUCOPENIA AND FELINE CHLAMYDOPHILA INFECTIONS
  - VACCINE AGAINST FELINE VIRAL RHINOTRACHEITIS, FELINE CALICIVIROSIS AND FELINE PANLEUCOPENIA
  - CHOLERA VACCINE, ORAL, LIVE
  - ANDEXANET ALFA
  - CHOLERA VACCINE (INACTIVATED, ORAL)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES)
  - HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
  - DENGUE TETRAVALENT VACCINE (LIVE, ATTENUATED)
  - MENINGOCOCCAL GROUP B VACCINE (RDNA, COMPONENT, ADSORBED)
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)
  - RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)
  - HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE (RECOMBINANT, ADSORBED)
  - HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)
  - HEPATITIS B (RDNA) VACCINE (ADJUVANTED, ADSORBED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - ROTAVIRUS VACCINE, LIVE
  - MENINGOCOCCAL GROUPS A, C, W-135 AND Y CONJUGATE VACCINE
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - MENINGOCOCCAL GROUPS A, C, W-135 AND Y CONJUGATE VACCINE
  - RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)
  - RESPIRATORY SYNCYTIAL VIRUS VACCINE (BIVALENT, RECOMBINANT)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)
  - ZOONOTIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL)
  - RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E
  - HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
  - INFLUENZA VACCINE (LIVE ATTENUATED, NASAL)
  - PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)
  - MENINGOCOCCAL GROUP B VACCINE (RDNA, COMPONENT, ADSORBED)
  - MENINGOCOCCAL GROUPS A, C, W-135 AND Y CONJUGATE VACCINE
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SPLIT VIRION, INACTIVATED, ADJUVANTED)
  - JAPANESE ENCEPHALITIS VACCINE (INACTIVATED, ADSORBED)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE (RECOMBINANT, ADSORBED)
  - PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (20-VALENT, ADSORBED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
  - COVID-19 VACCINE (RECOMBINANT, ADJUVANTED)
  - QUADRIVALENT INFLUENZA VACCINE (RECOMBINANT, PREPARED IN CELL CULTURE)
  - MENINGOCOCCAL GROUP A, C, W-135 AND Y CONJUGATE VACCINE
  - DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT), HEPATITIS B (RDNA), POLIOMYELITIS (INACTIVATED) AND HAEMOPHILUS TYPE B CONJUGATE VACCINE (ADSORBED)
  - HERPES ZOSTER VACCINE (RECOMBINANT, ADJUVANTED)
  - INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - EBOLA VACCINE (MVA-BN-FILO [RECOMBINANT])
  - MENINGOCOCCAL GROUP B VACCINE (RDNA, COMPONENT, ADSORBED)
  - HEPATITIS B (RDNA) VACCINE (ADJUVANTED, ADSORBED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 16, 18] (RECOMBINANT, ADJUVANTED, ADSORBED)
  - HEPATITIS A (INACTIVATED) AND HEPATITIS B (RDNA) (HAB) VACCINE (ADSORBED)
  - RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS PRE-FUSION F PROTEIN, ADJUVANTED WITH AS01E
  - ZOONOTIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)
  - HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)
  - HEPATITIS B (RDNA) VACCINE (ADJUVANTED, ADSORBED)
  - JAPANESE ENCEPHALITIS VACCINE (INACTIVATED, ADSORBED)
  - DIPHTHERIA (D), TETANUS (T), PERTUSSIS (ACELLULAR, COMPONENT) (PA), HEPATITIS B (RDNA) (HBV), POLIOMYELITIS (INACTIVATED) (IPV) AND HAEMOPHILUS INFLUENZAE TYPE-B (HIB) CONJUGATE VACCINE (ADSORBED)
  - PANDEMIC INFLUENZA VACCINE (H5N1) (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED)

exclusions_ema:
  - FLORBETABEN (18F)
  - PIFLUFOLASTAT (18F)
  - LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
  - SAMARIUM [153SM] LEXIDRONAM PENTASODIUM
  - IOFLUPANE (123I)
  - LUTETIUM (177LU) CHLORIDE
  - FLORBETAPIR (18F)
  - LUTETIUM (177LU) OXODOTREOTIDE
  - FLUCICLOVINE (18F)
  - IOFLUPANE (123L)
  - FLUTEMETAMOL (18F)
  - LUTETIUM (177 LU) CHLORIDE
  - 13C-UREA
  - SITAGLIPTIN, METFORMIN HYDROCHLORIDE
  - ""
  - NA
  - TECHNETIUM (99MTC) NOFETUMOMAB MERPENTAN
  - lutetium (177 Lu) chloride
  - fluciclovine (18F)
  - ioflupane (123l)
  - copper (64Cu) chloride
  - COPPER (64CU) CHLORIDE
  - piflufolastat (18F)
  - 13C-urea


# RUSSIA
in_language_russia: ru
out_language_russia: en
russia_drug_column: International non -parted or chemical name
russia_approval_date_column: The date of registration

split_exclusions_russia:
  - None

delimiters_russia:
  - "+"

# NAME RESOLVER
name_resolver_params:
  url: https://name-resolution-sri.renci.org/
  service: lookup
  autocomplete_setting: false
  id_limit: 10
  offset: 0
  biolink_type: ChemicalOrDrugOrTreatment


name_resolver_params_local:
  url: https://localhost:2433/
  service: lookup
  autocomplete_setting: false
  id_limit: 10
  offset: 0
  biolink_type: ChemicalOrDrugOrTreatment

name_reformatting_prompt: Reformat this drug name to include only active moieties separated by semicolons - return only the reformatted list with no additional text or explanations.


column_names:
  drug_name: drug_name
  nameres_first_label: curie_label
  id_correct_incorrect_tag_drug: llm_correct_incorrect
  llm_true_false_column_drug: llm_first_curie_correct
  curie_column: curie
  llm_improved_column_name: improved_id



biolink_type_drug: ChemicalOrDrugOrTreatment


# DRUG CATEGORY TAGS

enrichment_tag_radioisotope:
  diagnostic_or_radioisotope:
      input_col: label
      output_col: is_radioisotope_or_diagnostic_agent
      model_params:
        model: gpt-4o-mini
        prompt: Is this drug primarily used as a radiolabel or diagnostic agent? Return TRUE or FALSE only.
        temperature: 0.2


# enrichment_tag_allergen:
#   allergen:
#     input_col: label
#     output_col: is_allergen
#     model_params:
#       model: gpt-4o
#       prompt: Is this drug primarily used as an allergen for allergy testing? Return TRUE or FALSE only.
#       temperature: 0.2

# enrichment_tag_metallic_salt:
#   metallic_salt:
#     input_col: label
#     output_col: is_metallic_salt
#     model_params:
#       model: gpt-4o
#       prompt: Is this drug a simple metallic salt? Return TRUE or FALSE only.
#       temperature: 0.2

# enrichment_tag_no_therapeutic_value:
#   no_therapeutic_value:
#     input_col: label
#     output_col: is_no_therapeutic_value
#     model_params:
#       model: gpt-4o
#       prompt: Could this drug be classified as having little therapeutic value? For example, sterile water, tryptan blue, copper, soybean oil, evans blue, and cocaine are considered low therapeutic value. Return TRUE or FALSE only.
#       temperature: 0.2


enrichment_tags_ec:
  steroid:
    input_col: label
    output_col: is_steroid
    model_params: 
      model: gpt-4o-mini
      prompt: Is this drug a corticosteroid drug? Return TRUE or FALSE only.
      temperature: 0.2
  antibiotic:
    input_col: label
    output_col: is_antimicrobial
    model_params:
      model: gpt-4o
      prompt: "Are any of these drugs in any of the following drug classes: an antibiotic drug, an antiviral drug (usually end in '-vir' or '-udine'), an antiretroviral drug, an antiparasitic drug, or an antifungal drug? Return TRUE or FALSE only."
      temperature: 0.2
  chemotherapy:
    input_col: label
    output_col: is_chemotherapy
    model_params:
      model: gpt-4o-mini
      prompt: Is this drug a cytotoxic chemotherapy drug used to treat cancer? Return TRUE or FALSE only.
      temperature: 0.2
  glucose_regulator:
    input_col: label
    output_col: is_glucose_regulator
    model_params:
      model: gpt-4o-mini
      prompt: Is this drug a drug which is primarily used to regulate glucose levels? Return TRUE or FALSE only.
      temperature: 0.2
  vaccine_or_antigen:
    input_col: label
    output_col: is_vaccine_or_antigen
    model_params:
      model: gpt-4o-mini
      prompt: Is this drug a vaccine or antigen? Return TRUE or FALSE only.
      temperature: 0.2
  no_therapeutic_value:
    input_col: label
    output_col: is_no_therapeutic_value
    model_params:
      model: gpt-4o
      prompt: Could this drug be classified as having little potential therapeutic value? For example, sterile water, tryptan blue, copper, and soybean oil are considered low potential therapeutic value. Unusual drugs may still have therapeutic value - do not discount drugs just because they are not approve in the USA or Europe. Return TRUE or FALSE only.
      temperature: 0.2
  metallic_salt:
    input_col: label
    output_col: is_metallic_salt
    model_params:
      model: gpt-4o
      prompt: Is this drug a simple metallic salt? Return TRUE or FALSE only.
      temperature: 0.2
  allergen:
    input_col: label
    output_col: is_allergen
    model_params:
      model: gpt-4o
      prompt: Is this drug primarily used as an allergen for allergy testing? Return TRUE or FALSE only.
      temperature: 0.2




id_correct_incorrect_tag_drug:
  model_params:
    model: gpt-4o
    prompt: "Are the following concepts similar enough that they could be considered the same drug? Return only TRUE or FALSE. Provide no explanation."
    temperature: 0

llm_best_id_tag_drug:
  model_params:
    model: gpt-4o
    prompt: "Return ONLY the best ontological ID (e.g., 'PUBCHEM:00000001') from the following to represent the provided drug concept. Do not include the label or item number. If no matches, return NONE."
    temperature: 0

#options: localLlama openai
llm_to_use: openai


# APPROVAL TAGS
approval_tags:
  - "approved_usa"
  - "approved_eu"
  - "approved_japan"
  - "approved_india"
  - "approved_russia"


# LIST PROPERTIES
drug_list_properties:
  - drug_name
  - improved_id
  - ingredients_list
  - ingredient_ids
  - combination_therapy
  - alternate_ids
  - label

additional_drug_list_properties_usa:
  - marketing_status_usa

additional_drug_list_properties_ema:
  - marketing_status_europe

additional_drug_list_properties_purplebook:

additional_drug_list_properties_pmda:

additional_drug_list_properties_russia:

additional_drug_list_properties_india:




